{
    "symbol": "IQV",
    "quarter": 2,
    "year": 2022,
    "date": "2022-07-21 12:41:05",
    "content": " Research and development solutions second quarter revenue of $1.950 billion was up 3.1% reported and 6% at constant currency, and excluding all COVID-related work, organic growth at constant currency in R&DS was 22%. Please go ahead, your line is open. As Ron mentioned, constant--organic constant currency revenue growth for TAS excluding COVID was 10% in the quarter and also 10% for the first half, so again really we\u00e2\u0080\u0099re not seeing anything at all that\u00e2\u0080\u0099s changed versus the pandemic peak, or before the pandemic peak. Please go ahead, your line is open. Thank you, good morning. Please go ahead, your line is open. Please go ahead, your line is open. Please go ahead, your line is open. Please go ahead, your line is open. Thank you, good morning. Please go ahead, your line is open. Please go ahead, your line is open. Please go ahead, your line is open."
}